Endocrinology — MCQs
On this page
A 38-year-old woman presents with hypertension (170/105 mmHg), hypokalemia (2.9 mEq/L), and metabolic alkalosis. Plasma aldosterone is elevated at 35 ng/dL (normal 4-31) and plasma renin activity is suppressed at 0.2 ng/mL/hr (normal 0.5-3.5). CT scan shows a 2.5 cm left adrenal mass. She also reports recent diagnosis of hyperthyroidism and is being evaluated for a neck mass. Synthesize these findings to evaluate for an underlying unifying diagnosis requiring modified treatment approach.
A 55-year-old man with type 1 diabetes for 30 years is hospitalized for pneumonia. Despite appropriate antibiotic therapy, his insulin requirements have tripled. Blood glucose ranges from 250-400 mg/dL. He develops hypotension unresponsive to fluid resuscitation. Cortisol level is 2 μg/dL (normal 5-25), and ACTH is 320 pg/mL (normal 10-60). Evaluate the endocrine complication and synthesize the pathophysiological connection to his primary disease.
A 42-year-old woman presents with tremor, anxiety, and weight loss. TSH is 0.02 mIU/L, free T4 is 3.2 ng/dL, and T3 is 280 ng/dL (normal 80-180). Radioactive iodine uptake scan shows uniformly increased uptake of 45% at 24 hours (normal 10-30%). Thyroid-stimulating immunoglobulin is positive. Analyze the feedback mechanism disruption occurring in this patient's hypothalamic-pituitary-thyroid axis.
A 50-year-old man with obesity presents with fatigue, facial rounding, and proximal muscle weakness. Initial screening shows elevated 24-hour urinary free cortisol. Serum cortisol remains elevated after low-dose dexamethasone suppression test but suppresses with high-dose dexamethasone. ACTH level is 85 pg/mL (normal 10-60). Analyze these findings to determine the anatomical source of excess cortisol production.
A 35-year-old woman undergoes total thyroidectomy for papillary thyroid cancer. Two hours post-operatively, she develops perioral numbness and carpopedal spasm. Trousseau's sign is positive. Serum calcium is 6.8 mg/dL (normal 8.5-10.5). Analyze the pathophysiological mechanism linking the surgical procedure to her current presentation.
A 28-year-old woman with Addison's disease presents to the emergency department with severe vomiting and diarrhea for 2 days. She ran out of her medications 3 days ago. Blood pressure is 85/50 mmHg, heart rate 118/min. Laboratory results show sodium 128 mEq/L, potassium 6.2 mEq/L, glucose 65 mg/dL. Apply your understanding of adrenal physiology to determine the immediate hormonal deficiency causing her presentation.
A 62-year-old man with type 2 diabetes mellitus presents for routine follow-up. His HbA1c is 8.2% despite metformin and lifestyle modifications. His physician considers adding a GLP-1 receptor agonist. Apply physiological principles to predict the expected effects of this medication on his glucose homeostasis.
A 45-year-old woman presents with heat intolerance, palpitations, and weight loss despite increased appetite. Physical examination reveals a diffusely enlarged thyroid gland, warm moist skin, and fine tremor. Laboratory tests show TSH <0.01 mIU/L (normal 0.5-5.0), free T4 4.5 ng/dL (normal 0.9-1.7), and positive TSH receptor antibodies. She is started on methimazole. Apply your knowledge of thyroid physiology to explain the mechanism by which this medication will restore euthyroid state.
Insulin is secreted along with which of the following molecules in a 1:1 molar ratio?
Aldosterone regulates extracellular volume and potassium homeostasis by binding to its receptors present in all, EXCEPT:
Endocrinology Indian Medical PG Practice Questions and MCQs
Question 1: A 38-year-old woman presents with hypertension (170/105 mmHg), hypokalemia (2.9 mEq/L), and metabolic alkalosis. Plasma aldosterone is elevated at 35 ng/dL (normal 4-31) and plasma renin activity is suppressed at 0.2 ng/mL/hr (normal 0.5-3.5). CT scan shows a 2.5 cm left adrenal mass. She also reports recent diagnosis of hyperthyroidism and is being evaluated for a neck mass. Synthesize these findings to evaluate for an underlying unifying diagnosis requiring modified treatment approach.
- A. Carney complex requiring cardiac myxoma screening before adrenal surgery
- B. Ectopic ACTH syndrome from thyroid carcinoma causing bilateral adrenal hyperplasia
- C. Coincidental adrenal adenoma and Graves' disease requiring separate standard treatments
- D. Isolated aldosterone-producing adenoma requiring unilateral adrenalectomy only
- E. Multiple endocrine neoplasia type 2 requiring RET proto-oncogene testing and comprehensive screening (Correct Answer)
Explanation: ***Multiple endocrine neoplasia type 2 requiring RET proto-oncogene testing and comprehensive screening*** - The combination of a **thyroid neck mass** and an **adrenal mass** in a young patient necessitates screening for **MEN 2**, which includes **Medullary Thyroid Carcinoma** and **Pheochromocytoma**. - While the labs initially suggest **primary hyperaldosteronism**, the presence of multi-organ endocrine pathology requires **RET proto-oncogene** testing to rule out life-threatening conditions before surgery. *Carney complex requiring cardiac myxoma screening before adrenal surgery* - **Carney complex** typically presents with **ACTH-independent Cushing syndrome** due to primary pigmented nodular adrenocortical disease, not primary hyperaldosteronism. - It is characterized by **skin lentigines**, **myxomas**, and **pituitary adenomas**, which are not mentioned in this patient's presentation. *Ectopic ACTH syndrome from thyroid carcinoma causing bilateral adrenal hyperplasia* - **Ectopic ACTH** would lead to high **cortisol levels** and **hypercortisolism** clinical features rather than isolated elevated aldosterone and suppressed renin. - The CT scan identified a **unilateral 2.5 cm mass** rather than the **bilateral adrenal hyperplasia** typically seen with ectopic ACTH production. *Coincidental adrenal adenoma and Graves' disease requiring separate standard treatments* - While possible, the presence of a **neck mass** (often discrete) is less characteristic of **Graves' disease**, which usually presents with diffuse goiter. - In medical students' exams, multiple endocrine findings are rarely coincidental and usually point toward a **unifying genetic syndrome**. *Isolated aldosterone-producing adenoma requiring unilateral adrenalectomy only* - The **aldosterone-to-renin ratio (ARR)** of 175 supports **Conn syndrome**, but this diagnosis fails to account for the patient's **neck mass** and **hyperthyroidism**. - Proceeding directly to adrenalectomy without ruling out a **Pheochromocytoma** in a potential MEN patient could lead to a **hypertensive crisis** and death during surgery.
Question 2: A 55-year-old man with type 1 diabetes for 30 years is hospitalized for pneumonia. Despite appropriate antibiotic therapy, his insulin requirements have tripled. Blood glucose ranges from 250-400 mg/dL. He develops hypotension unresponsive to fluid resuscitation. Cortisol level is 2 μg/dL (normal 5-25), and ACTH is 320 pg/mL (normal 10-60). Evaluate the endocrine complication and synthesize the pathophysiological connection to his primary disease.
- A. Isolated aldosterone deficiency from diabetic nephropathy
- B. Pituitary apoplexy from infection causing secondary adrenal insufficiency
- C. Medication-induced suppression of adrenal function from chronic steroid use
- D. Autoimmune polyglandular syndrome type 2 with adrenal insufficiency complicating stress response (Correct Answer)
- E. Sepsis-induced adrenal hemorrhage causing acute adrenal crisis
Explanation: ***Autoimmune polyglandular syndrome type 2 with adrenal insufficiency complicating stress response*** - The combination of **Type 1 Diabetes** and **Addison's disease** (primary adrenal insufficiency) is a hallmark of **Autoimmune Polyglandular Syndrome type 2 (APS-2)**, often including thyroid disease. - The labs show **low cortisol (2 μg/dL)** and **high ACTH (320 pg/mL)**, confirming a **primary adrenal** failure where the gland cannot respond to compensatory pituitary signals during the stress of pneumonia. *Isolated aldosterone deficiency from diabetic nephropathy* - While diabetic nephropathy can cause **hyporeninemic hypoaldosteronism**, it would not explain the **profoundly low cortisol** or high ACTH levels seen here. - This condition typically presents with **hyperkalemia** rather than the refractory hypotension and acute adrenal crisis triggered by infection. *Pituitary apoplexy from infection causing secondary adrenal insufficiency* - Pituitary failure would result in **low ACTH** or inappropriately normal ACTH levels, which contradicts this patient's **highly elevated ACTH**. - Apoplexy usually presents with sudden severe **headache**, visual field defects, or ophthalmoplegia, which are not mentioned in this clinical scenario. *Medication-induced suppression of adrenal function from chronic steroid use* - Chronic steroid use causes **secondary adrenal insufficiency** due to the suppression of the hypothalamic-pituitary-adrenal axis, leading to **low ACTH** levels. - This patient's **ACTH is 320 pg/mL**, which is significantly elevated, indicating the defect is at the level of the **adrenal gland** itself (primary insufficiency). *Sepsis-induced adrenal hemorrhage causing acute adrenal crisis* - While sepsis can cause **Waterhouse-Friderichsen syndrome**, it is far less likely in a patient with a 30-year history of another **autoimmune disease** (T1DM). - Bilateral adrenal hemorrhage typically occurs in the setting of severe **meningococcemia** or DIC, whereas this patient's history strongly points toward an underlying **autoimmune polyglandular** etiology.
Question 3: A 42-year-old woman presents with tremor, anxiety, and weight loss. TSH is 0.02 mIU/L, free T4 is 3.2 ng/dL, and T3 is 280 ng/dL (normal 80-180). Radioactive iodine uptake scan shows uniformly increased uptake of 45% at 24 hours (normal 10-30%). Thyroid-stimulating immunoglobulin is positive. Analyze the feedback mechanism disruption occurring in this patient's hypothalamic-pituitary-thyroid axis.
- A. Defective thyroid hormone receptor in the pituitary causing inappropriate TSH release
- B. Peripheral resistance to thyroid hormone at target tissues requiring higher levels
- C. Pituitary adenoma autonomously secreting TSH despite elevated thyroid hormones
- D. Loss of negative feedback at the hypothalamus causing increased TRH secretion
- E. Antibody-mediated TSH receptor activation bypassing normal feedback inhibition (Correct Answer)
Explanation: ***Antibody-mediated TSH receptor activation bypassing normal feedback inhibition*** - In **Graves' disease**, **thyroid-stimulating immunoglobulins (TSI)** bind to and activate the **TSH receptor**, leading to autonomous production of T3 and T4. - While the elevated thyroid hormones provide strong **negative feedback** to suppress pituitary **TSH**, they cannot stop the antibody-driven stimulation of the thyroid gland. *Defective thyroid hormone receptor in the pituitary causing inappropriate TSH release* - This describes **Resistance to Thyroid Hormone (RTH)**, where the pituitary is insensitive to feedback, typically resulting in **elevated TSH** levels. - The patient's **TSH is suppressed** (0.02 mIU/L), which contradicts a pituitary receptor primary defect where TSH would be high or inappropriately normal. *Peripheral resistance to thyroid hormone at target tissues requiring higher levels* - **Peripheral resistance** would present with symptoms of **hypothyroidism** or a mix of features, despite high serum hormone levels. - This patient demonstrates clear **thyrotoxicosis** symptoms (anxiety, weight loss, tremor) and **suppressed TSH**, indicating active hormone action and intact feedback. *Pituitary adenoma autonomously secreting TSH despite elevated thyroid hormones* - A **TSH-secreting pituitary adenoma** would result in high levels of T3/T4 accompanied by **elevated or inappropriately normal TSH**. - The uniform **radioactive iodine uptake** in this case, paired with **positive TSI**, confirms a primary thyroid pathology rather than a central pituitary cause. *Loss of negative feedback at the hypothalamus causing increased TRH secretion* - **Loss of negative feedback** at the hypothalamus would lead to high **TRH**, which in turn stimulates the pituitary to release high levels of **TSH**. - Since the patient's **TSH is low**, the hypothalamus-pituitary feedback loop is functioning correctly by sensing the excess hormone and shutting down endogenous stimulation.
Question 4: A 50-year-old man with obesity presents with fatigue, facial rounding, and proximal muscle weakness. Initial screening shows elevated 24-hour urinary free cortisol. Serum cortisol remains elevated after low-dose dexamethasone suppression test but suppresses with high-dose dexamethasone. ACTH level is 85 pg/mL (normal 10-60). Analyze these findings to determine the anatomical source of excess cortisol production.
- A. Adrenal adenoma with autonomous cortisol secretion
- B. Pituitary adenoma producing excess ACTH (Correct Answer)
- C. Exogenous glucocorticoid administration
- D. Primary adrenal hyperplasia independent of ACTH
- E. Ectopic ACTH production from small cell lung cancer
Explanation: ***Pituitary adenoma producing excess ACTH*** - The elevated **ACTH level (85 pg/mL)** confirms the patient has **ACTH-dependent Cushing syndrome**, which points toward either a pituitary source or an ectopic source. - Cortisol suppression with a **high-dose dexamethasone suppression test (HDDST)** is characteristic of **Cushing disease** (pituitary adenoma), as these tumors retain partial sensitivity to negative feedback. *Adrenal adenoma with autonomous cortisol secretion* - Adrenal adenomas secrete cortisol autonomously, which would lead to a **suppressed ACTH level** (less than 5 pg/mL) due to negative feedback on the pituitary. - These tumors do not suppress with dexamethasone because they are not under the control of the **hypothalamic-pituitary-adrenal (HPA) axis**. *Exogenous glucocorticoid administration* - Factitious or therapeutic use of glucocorticoids results in **low ACTH levels** and low 24-hour urinary free cortisol (unless testing for synthetic analogs). - It leads to **bilateral adrenal atrophy** rather than the hyperfunctioning state indicated by the clinical and lab markers in this patient. *Primary adrenal hyperplasia independent of ACTH* - This condition involves autonomous cortisol production by the adrenal glands, leading to an appropriately **suppressed serum ACTH**. - Like adrenal adenomas, this pathology will not demonstrate suppression during a **high-dose dexamethasone test**. *Ectopic ACTH production from small cell lung cancer* - Ectopic sources typically present with **extremely high ACTH levels** and fail to suppress with **high-dose dexamethasone** because the tumors lack legitimate glucocorticoid receptors. - Patients with ectopic ACTH often have more severe, rapid-onset symptoms such as **profound hypokalemia** and significant hyperpigmentation.
Question 5: A 35-year-old woman undergoes total thyroidectomy for papillary thyroid cancer. Two hours post-operatively, she develops perioral numbness and carpopedal spasm. Trousseau's sign is positive. Serum calcium is 6.8 mg/dL (normal 8.5-10.5). Analyze the pathophysiological mechanism linking the surgical procedure to her current presentation.
- A. Postoperative hypomagnesemia causing functional hypoparathyroidism
- B. Surgical stress-induced calcitonin release causing calcium deposition in bone
- C. Thyroid hormone withdrawal causing decreased intestinal calcium absorption
- D. Inadvertent removal of parathyroid glands causing decreased PTH and impaired calcium mobilization (Correct Answer)
- E. Acute vitamin D deficiency from loss of thyroid conversion enzymes
Explanation: ***Inadvertent removal of parathyroid glands causing decreased PTH and impaired calcium mobilization*** - This patient presents with **hypocalcemia** (6.8 mg/dL) and signs of **neuromuscular excitability** (Trousseau’s sign, carpopedal spasm) due to accidental **iatalogenic hypoparathyroidism** following total thyroidectomy. - The sudden loss of **Parathyroid Hormone (PTH)** results in failure to mobilize calcium from bone and a decrease in **renal calcium reabsorption**, leading to acute drops in serum calcium. *Postoperative hypomagnesemia causing functional hypoparathyroidism* - While **hypomagnesemia** can cause functional hypoparathyroidism, it is typically a chronic issue or related to malabsorption rather than an immediate surgical complication of thyroidectomy. - The primary mechanism in this clinical context is direct **mechanical trauma** or vascular compromise to the parathyroid glands themselves. *Surgical stress-induced calcitonin release causing calcium deposition in bone* - **Calcitonin** is secreted by parafollicular C-cells, but its effect on acute serum calcium levels in adults is relatively minor and transient. - Surgical removal of the thyroid would actually decrease calcitonin levels, making this an unlikely mechanism for severe **acute hypocalcemia**. *Thyroid hormone withdrawal causing decreased intestinal calcium absorption* - **Thyroid hormone** withdrawal does not occur two hours post-operatively, as T4 has a half-life of about 7 days. - Intestinal calcium absorption is primarily regulated by **1,25-dihydroxyvitamin D**, which is dependent on PTH stimulation in the kidneys, not direct thyroid hormone action. *Acute vitamin D deficiency from loss of thyroid conversion enzymes* - The thyroid gland is not a site for the **hydroxylation** or conversion of Vitamin D; these processes occur in the **liver** and **kidneys**. - **Vitamin D deficiency** would typically present over a longer period and is not a common immediate consequence of a thyroidectomy procedure.
Question 6: A 28-year-old woman with Addison's disease presents to the emergency department with severe vomiting and diarrhea for 2 days. She ran out of her medications 3 days ago. Blood pressure is 85/50 mmHg, heart rate 118/min. Laboratory results show sodium 128 mEq/L, potassium 6.2 mEq/L, glucose 65 mg/dL. Apply your understanding of adrenal physiology to determine the immediate hormonal deficiency causing her presentation.
- A. Primary epinephrine deficiency from adrenal medulla dysfunction
- B. Combined cortisol and aldosterone deficiency with loss of mineralocorticoid and glucocorticoid effects (Correct Answer)
- C. ACTH excess causing direct renal sodium wasting
- D. Isolated cortisol deficiency with intact mineralocorticoid function
- E. Isolated aldosterone deficiency causing electrolyte abnormalities only
Explanation: ***Combined cortisol and aldosterone deficiency with loss of mineralocorticoid and glucocorticoid effects*** - **Addison’s disease** involves the destruction of all three layers of the **adrenal cortex**, leading to a dual deficiency of **cortisol** and **aldosterone**. - This combination causes the classic **adrenal crisis** presentation: **hypotension** and **hypoglycemia** (due to low cortisol) along with **hyponatremia** and **hyperkalemia** (due to low aldosterone). *Primary epinephrine deficiency from adrenal medulla dysfunction* - **Addison’s disease** primarily affects the **adrenal cortex**; the **adrenal medulla** and its production of **epinephrine** are typically spared. - While epinephrine assists in the stress response, its absence is not the primary cause of the severe **hyponatremia** or **hyperkalemia** seen in an adrenal crisis. *ACTH excess causing direct renal sodium wasting* - While **ACTH** is elevated in primary adrenal insufficiency due to lack of feedback inhibition, it does not directly cause **renal sodium wasting**. - High **ACTH** levels are responsible for **hyperpigmentation**, but the sodium loss is strictly due to the lack of **aldosterone** acting on the distal tubules. *Isolated cortisol deficiency with intact mineralocorticoid function* - This pattern is characteristic of **secondary adrenal insufficiency** (pituitary failure), where the **renin-angiotensin system** keeps aldosterone levels normal. - The presence of **hyperkalemia** and severe volume depletion in this patient confirms that **mineralocorticoid** function is significantly impaired. *Isolated aldosterone deficiency causing electrolyte abnormalities only* - Isolated aldosterone deficiency (hyporeninemic hypoaldosteronism) would explain high potassium but not the severe **hypoglycemia** or total vascular collapse. - **Cortisol** is essential for maintaining **vascular tone** and **gluconeogenesis**; its absence is a critical component of the patient's presentation.
Question 7: A 62-year-old man with type 2 diabetes mellitus presents for routine follow-up. His HbA1c is 8.2% despite metformin and lifestyle modifications. His physician considers adding a GLP-1 receptor agonist. Apply physiological principles to predict the expected effects of this medication on his glucose homeostasis.
- A. Inhibition of renal glucose reabsorption at the proximal tubule
- B. Increased insulin secretion independent of glucose levels with decreased glucagon
- C. Glucose-dependent insulin secretion, decreased glucagon, and delayed gastric emptying (Correct Answer)
- D. Direct stimulation of peripheral glucose uptake via GLUT4 translocation
- E. Enhanced hepatic glucose uptake through GLUT2 upregulation
Explanation: ***Glucose-dependent insulin secretion, decreased glucagon, and delayed gastric emptying*** - **GLP-1 receptor agonists** enhance insulin secretion from **pancreatic beta cells** in a **glucose-dependent** manner, which significantly minimizes the risk of hypoglycemia. - They also suppress inappropriately high **glucagon secretion** from alpha cells and slow **gastric emptying**, which reduces the rate of postprandial glucose absorption. *Inhibition of renal glucose reabsorption at the proximal tubule* - This is the primary mechanism of **SGLT2 inhibitors** (e.g., empagliflozin), not GLP-1 receptor agonists. - SGLT2 inhibitors lower blood sugar by promoting **glucosuria**, whereas GLP-1 agonists work via the **incretin pathway**. *Increased insulin secretion independent of glucose levels with decreased glucagon* - Medications like **Sulfonylureas** cause insulin secretion **independently of glucose levels**, which often leads to hypoglycemia. - While GLP-1 agonists do decrease glucagon, their effect on insulin is strictly **glucose-dependent**, meaning they only work when blood sugar is elevated. *Direct stimulation of peripheral glucose uptake via GLUT4 translocation* - This is the primary physiological effect of **endogenous insulin** acting on skeletal muscle and adipose tissue. - GLP-1 agonists do not directly stimulate **GLUT4 translocation**; they act as secretagogues to trigger the release of insulin, which then facilitates this process. *Enhanced hepatic glucose uptake through GLUT2 upregulation* - **GLUT2** is a bidirectional transporter found in the liver that is not typically regulated by the upregulation of the transporter protein via GLP-1 drugs. - While GLP-1 agonists reduce **hepatic glucose production** by suppressing glucagon, they do not manage homeostasis through direct **GLUT2 upregulation**.
Question 8: A 45-year-old woman presents with heat intolerance, palpitations, and weight loss despite increased appetite. Physical examination reveals a diffusely enlarged thyroid gland, warm moist skin, and fine tremor. Laboratory tests show TSH <0.01 mIU/L (normal 0.5-5.0), free T4 4.5 ng/dL (normal 0.9-1.7), and positive TSH receptor antibodies. She is started on methimazole. Apply your knowledge of thyroid physiology to explain the mechanism by which this medication will restore euthyroid state.
- A. Blocks iodide uptake by inhibiting the sodium-iodide symporter
- B. Inhibits thyroid peroxidase-mediated iodination of thyroglobulin (Correct Answer)
- C. Enhances hepatic metabolism of circulating thyroid hormones
- D. Increases peripheral conversion of T4 to reverse T3
- E. Competitively blocks TSH receptors on thyroid follicular cells
Explanation: ***Inhibits thyroid peroxidase-mediated iodination of thyroglobulin*** - **Methimazole** belongs to the thionamide class and works by inhibiting the enzyme **thyroid peroxidase (TPO)**. - This action prevents the **organification** of iodide and the **coupling** of iodotyrosines, effectively halting the synthesis of new thyroid hormones. *Blocks iodide uptake by inhibiting the sodium-iodide symporter* - This mechanism is characteristic of **anion inhibitors** like **perchlorate** or thiocyanate. - **Methimazole** does not interfere with the active transport of iodide into the thyroid follicular cell. *Enhances hepatic metabolism of circulating thyroid hormones* - No first-line antithyroid medications work by increasing the **hepatic clearance** or metabolism of T3/T4. - Management of hyperthyroidism focuses on decreasing **hormone production** or blocking peripheral effects rather than metabolic destruction. *Increases peripheral conversion of T4 to reverse T3* - While **Propylthiouracil (PTU)** inhibits the peripheral conversion of T4 to active T3, **methimazole** lacks this specific peripheral inhibitory effect. - Increasing **reverse T3** is not a primary therapeutic goal or a mechanism of action for methimazole. *Competitively blocks TSH receptors on thyroid follicular cells* - Methimazole does not act as a **receptor antagonist**; it acts intracellularly on the biosynthetic pathway. - In **Graves' disease**, TSH receptor antibodies (TRAb) stimulate the receptor, but methimazole reduces the resulting **hormone output** instead of blocking the antibody-receptor binding.
Question 9: Insulin is secreted along with which of the following molecules in a 1:1 molar ratio?
- A. Pancreatic polypeptide
- B. Glucagon
- C. GLP-1 (Correct Answer)
- D. Somatostatin
Explanation: **Explanation:** The correct answer is **C-Peptide** (Note: In the provided options, **GLP-1** is marked as correct, but physiologically, **C-peptide** is the molecule secreted in a 1:1 molar ratio with insulin. If this is a specific recall question where GLP-1 was the intended answer, it refers to the "Incretin Effect," though C-peptide remains the gold standard for 1:1 secretion). **1. Why C-Peptide (and the concept of Proinsulin) is the standard:** Insulin is synthesized in the pancreatic beta cells as **Proinsulin**. Before secretion, proinsulin is cleaved by endopeptidases into two products: **Active Insulin** and **Connecting peptide (C-peptide)**. Because they originate from the same precursor molecule, they are packaged into secretory granules and released into the portal circulation in an equimolar (1:1) ratio. **2. Analysis of Options:** * **A. Pancreatic Polypeptide:** Secreted by PP cells (F cells) of the pancreas; it regulates pancreatic exocrine secretions but is not co-secreted with insulin. * **B. Glucagon:** Secreted by Alpha cells. It is an antagonist to insulin; its secretion is actually inhibited by insulin. * **C. GLP-1:** An incretin hormone secreted by L-cells of the intestine. While it *stimulates* insulin secretion, it is not secreted from the pancreas in a 1:1 ratio. (In some exams, this may be highlighted to emphasize the *Incretin Effect*). * **D. Somatostatin:** Secreted by Delta cells; it acts as a universal inhibitor of both insulin and glucagon. **Clinical Pearls for NEET-PG:** * **Diagnostic Use:** C-peptide levels are used to distinguish between **Type 1 DM** (low/absent C-peptide) and **Type 2 DM** (normal/high C-peptide). * **Factitious Hypoglycemia:** In cases of exogenous insulin overdose, insulin levels will be high, but C-peptide levels will be **low** (since synthetic insulin lacks C-peptide). * **Half-life:** C-peptide has a longer half-life than insulin, making it a more stable marker of endogenous beta-cell function.
Question 10: Aldosterone regulates extracellular volume and potassium homeostasis by binding to its receptors present in all, EXCEPT:
- A. Liver (Correct Answer)
- B. Colon
- C. Hippocampus
- D. Distal nephron
Explanation: **Explanation:** Aldosterone is a steroid hormone produced by the zona glomerulosa of the adrenal cortex. It acts by binding to the **Mineralocorticoid Receptor (MR)**, a nuclear receptor that regulates gene expression to increase sodium reabsorption and potassium excretion. **Why Liver is the correct answer:** The liver is the primary site for the **metabolism and conjugation** of aldosterone (converting it to tetrahydroaldosterone-3-glucuronide for excretion), but it does not contain functional mineralocorticoid receptors for aldosterone action. Therefore, the liver does not play a direct role in aldosterone-mediated electrolyte or volume regulation. **Analysis of other options:** * **Distal Nephron:** This is the primary site of action. Aldosterone acts on the **Principal cells** of the late distal tubule and collecting duct to increase the expression of ENaC (epithelial sodium channels) and Na+/K+ ATPase, leading to sodium retention and potassium secretion. * **Colon:** Aldosterone receptors in the distal colon promote the reabsorption of sodium and water from the intestinal lumen into the blood, similar to its action in the kidney. * **Hippocampus:** Interestingly, the brain (specifically the hippocampus) expresses high levels of Mineralocorticoid Receptors. While not involved in volume regulation, these receptors in the CNS are involved in the stress response, mood regulation, and cognitive functions. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Aldosterone acts on **Principal cells** (Na+ reabsorption/K+ secretion) and **Alpha-intercalated cells** (H+ secretion via H+-ATPase). * **Conn’s Syndrome:** Primary hyperaldosteronism presents with the triad of **Hypertension, Hypokalemia, and Metabolic Alkalosis.** * **Aldosterone Escape:** In primary hyperaldosteronism, edema is usually absent because the body compensates for chronic volume expansion through ANP (Atrial Natriuretic Peptide), leading to "escape" from further sodium retention.
Practice by Chapter
Principles of Endocrine Regulation
Practice Questions
Hypothalamus and Pituitary Gland
Practice Questions
Thyroid Physiology
Practice Questions
Adrenal Cortex and Medulla
Practice Questions
Pancreatic Hormones and Glucose Metabolism
Practice Questions
Calcium and Phosphate Homeostasis
Practice Questions
Growth Hormone and Growth Factors
Practice Questions
Endocrine Regulation of Metabolism
Practice Questions
Hormone Receptors and Signaling
Practice Questions
Assessment of Endocrine Function
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free